dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Hepatocyte Growth Factor/MET Activator Rescues
Hepatocyte Growth Factor MET Activator Rescues Working Memory Deficits After Repeated Mild Traumatic Brain Injury bioRxiv Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted HGF independent potentiation of EGFR action by c Met Oncogene Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease
Pay in 4 interest-free payments of $7.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19



